Scott Dreyer - 10 Feb 2023 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Colleen Tupper as Attorney-In-Fact For Scott Dreyer
Issuer symbol
COLL
Transactions as of
10 Feb 2023
Net transactions value
-$570,470
Form type
4
Filing time
14 Feb 2023, 16:15:57 UTC
Previous filing
11 Jan 2023
Next filing
03 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +44,275 +43% $0.000000 147,073 10 Feb 2023 Direct F1
transaction COLL Common Stock Award +22,459 +15% 169,532 10 Feb 2023 Direct F2
transaction COLL Common Stock Tax liability $388,651 -14,529 -8.6% $26.75 155,003 10 Feb 2023 Direct F3
transaction COLL Common Stock Tax liability $181,820 -6,797 -4.4% $26.75 148,206 10 Feb 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
F2 Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 22,459 performance share units granted in the issuer's three prior fiscal years.
F3 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F4 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.